US Stock MarketDetailed Quotes

Nemaura Medical (NMRD)

Watchlist
  • 0.000100
  • 0.0000000.00%
15min DelayClose May 6 12:00 ET
4.04KMarket Cap0.00P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Nemaura Medical (NMRD) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Dec 31, 2023
(Q2)Sep 30, 2023
(Q1)Jun 30, 2023
(FY)Mar 31, 2023
(Q4)Mar 31, 2023
(Q3)Dec 31, 2022
(Q2)Sep 30, 2022
(Q1)Jun 30, 2022
(FY)Mar 31, 2022
(Q4)Mar 31, 2022
Total revenue
0
0
0
-84.71%77.04K
0
-98.36%3.02K
74.03K
0
503.91K
320.28K
Operating revenue
--0
--0
--0
-84.71%77.04K
--0
-98.36%3.02K
--74.03K
--0
--503.91K
--320.28K
Cost of revenue
0
0
0
351.19%1.55M
759.83%1.48M
-98.28%2.97K
72.36K
0
344.3K
171.91K
Gross profit
0
0
0
-1,025.02%-1.48M
-1,096.23%-1.48M
-99.59%46
1.67K
0
159.61K
148.37K
Operating expense
-5.09%1.54M
26.09%2.05M
28.86%2.06M
-7.65%7.14M
79.43%4.65M
-9.96%1.62M
-5.17%1.63M
-1.44%1.6M
68.53%7.73M
87.83%2.59M
Selling and administrative expenses
1.62%1.25M
13.85%1.56M
19.03%1.51M
-9.28%5.6M
102.36%4.09M
-11.58%1.23M
-4.12%1.37M
-4.87%1.27M
103.59%6.17M
86.61%2.02M
-General and administrative expense
1.62%1.25M
13.85%1.56M
19.03%1.51M
-9.28%5.6M
102.36%4.09M
-11.58%1.23M
-4.12%1.37M
-4.87%1.27M
103.59%6.17M
86.61%2.02M
Research and development costs
-26.07%291.1K
91.32%491.8K
66.57%549.76K
-1.18%1.54M
-2.02%557.75K
-4.51%393.75K
-10.40%257.06K
14.41%330.06K
0.15%1.56M
92.29%569.28K
Operating profit
5.09%-1.54M
-26.22%-2.05M
-28.86%-2.06M
-13.80%-8.62M
-150.84%-6.13M
9.40%-1.62M
5.26%-1.62M
1.44%-1.6M
-65.05%-7.57M
-77.07%-2.44M
Net non-operating interest income expense
-77.82%-1.93M
49.01%-824.81K
54.75%-657.01K
3.81%-6.41M
-48.21%-2.26M
33.93%-1.08M
9.10%-1.62M
15.73%-1.45M
-232.06%-6.67M
-40.28%-1.52M
Non-operating interest expense
77.82%1.93M
-49.01%824.81K
-54.75%657.01K
-3.81%6.41M
48.21%2.26M
-33.93%1.08M
-9.10%1.62M
-15.73%1.45M
232.06%6.67M
40.28%1.52M
Other net income (expense)
31.79%1.31M
372.44%1.67M
113.35%112.08K
883.96K
3.7M
990.53K
-613.69K
-839.58K
Gain on sale of security
31.79%1.31M
372.44%1.67M
113.35%112.08K
--1.86M
--4.68M
--990.53K
---613.69K
---839.58K
----
----
Special income (charges)
----
----
----
---980.04K
----
----
----
----
--0
----
-Less:Impairment of capital assets
----
----
----
--980.04K
----
----
----
----
--0
----
Income before tax
-25.94%-2.16M
68.79%-1.2M
33.06%-2.6M
0.66%-14.14M
-18.03%-4.68M
49.99%-1.72M
-10.34%-3.86M
-16.30%-3.89M
-115.90%-14.24M
-60.86%-3.97M
Income tax
0
-4.30%-350.26K
Net income
-25.94%-2.16M
68.79%-1.2M
33.06%-2.6M
-1.85%-14.14M
-29.46%-4.68M
49.99%-1.72M
-10.34%-3.86M
-16.30%-3.89M
-121.88%-13.89M
-69.77%-3.62M
Net income continuous Operations
-25.94%-2.16M
68.79%-1.2M
33.06%-2.6M
-1.85%-14.14M
-29.46%-4.68M
49.99%-1.72M
-10.34%-3.86M
-16.30%-3.89M
-121.88%-13.89M
-69.77%-3.62M
Minority interest income
Net income attributable to the parent company
-25.94%-2.16M
68.79%-1.2M
33.06%-2.6M
-1.85%-14.14M
-29.46%-4.68M
49.99%-1.72M
-10.34%-3.86M
-16.30%-3.89M
-121.88%-13.89M
-69.77%-3.62M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-25.94%-2.16M
68.79%-1.2M
33.06%-2.6M
-1.85%-14.14M
-29.46%-4.68M
49.99%-1.72M
-10.34%-3.86M
-16.30%-3.89M
-121.88%-13.89M
-69.77%-3.62M
Basic earnings per share
0.00%-0.07
68.75%-0.05
43.75%-0.09
3.39%-0.57
-20.00%-0.18
53.33%-0.07
-6.67%-0.16
-14.29%-0.16
-110.71%-0.59
-66.67%-0.15
Diluted earnings per share
0.00%-0.07
68.75%-0.05
43.75%-0.09
3.39%-0.57
-20.00%-0.18
53.33%-0.07
-6.67%-0.16
-14.29%-0.16
-110.71%-0.59
-66.67%-0.15
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Dec 31, 2023(Q2)Sep 30, 2023(Q1)Jun 30, 2023(FY)Mar 31, 2023(Q4)Mar 31, 2023(Q3)Dec 31, 2022(Q2)Sep 30, 2022(Q1)Jun 30, 2022(FY)Mar 31, 2022(Q4)Mar 31, 2022
Total revenue 000-84.71%77.04K0-98.36%3.02K74.03K0503.91K320.28K
Operating revenue --0--0--0-84.71%77.04K--0-98.36%3.02K--74.03K--0--503.91K--320.28K
Cost of revenue 000351.19%1.55M759.83%1.48M-98.28%2.97K72.36K0344.3K171.91K
Gross profit 000-1,025.02%-1.48M-1,096.23%-1.48M-99.59%461.67K0159.61K148.37K
Operating expense -5.09%1.54M26.09%2.05M28.86%2.06M-7.65%7.14M79.43%4.65M-9.96%1.62M-5.17%1.63M-1.44%1.6M68.53%7.73M87.83%2.59M
Selling and administrative expenses 1.62%1.25M13.85%1.56M19.03%1.51M-9.28%5.6M102.36%4.09M-11.58%1.23M-4.12%1.37M-4.87%1.27M103.59%6.17M86.61%2.02M
-General and administrative expense 1.62%1.25M13.85%1.56M19.03%1.51M-9.28%5.6M102.36%4.09M-11.58%1.23M-4.12%1.37M-4.87%1.27M103.59%6.17M86.61%2.02M
Research and development costs -26.07%291.1K91.32%491.8K66.57%549.76K-1.18%1.54M-2.02%557.75K-4.51%393.75K-10.40%257.06K14.41%330.06K0.15%1.56M92.29%569.28K
Operating profit 5.09%-1.54M-26.22%-2.05M-28.86%-2.06M-13.80%-8.62M-150.84%-6.13M9.40%-1.62M5.26%-1.62M1.44%-1.6M-65.05%-7.57M-77.07%-2.44M
Net non-operating interest income expense -77.82%-1.93M49.01%-824.81K54.75%-657.01K3.81%-6.41M-48.21%-2.26M33.93%-1.08M9.10%-1.62M15.73%-1.45M-232.06%-6.67M-40.28%-1.52M
Non-operating interest expense 77.82%1.93M-49.01%824.81K-54.75%657.01K-3.81%6.41M48.21%2.26M-33.93%1.08M-9.10%1.62M-15.73%1.45M232.06%6.67M40.28%1.52M
Other net income (expense) 31.79%1.31M372.44%1.67M113.35%112.08K883.96K3.7M990.53K-613.69K-839.58K
Gain on sale of security 31.79%1.31M372.44%1.67M113.35%112.08K--1.86M--4.68M--990.53K---613.69K---839.58K--------
Special income (charges) ---------------980.04K------------------0----
-Less:Impairment of capital assets --------------980.04K------------------0----
Income before tax -25.94%-2.16M68.79%-1.2M33.06%-2.6M0.66%-14.14M-18.03%-4.68M49.99%-1.72M-10.34%-3.86M-16.30%-3.89M-115.90%-14.24M-60.86%-3.97M
Income tax 0-4.30%-350.26K
Net income -25.94%-2.16M68.79%-1.2M33.06%-2.6M-1.85%-14.14M-29.46%-4.68M49.99%-1.72M-10.34%-3.86M-16.30%-3.89M-121.88%-13.89M-69.77%-3.62M
Net income continuous Operations -25.94%-2.16M68.79%-1.2M33.06%-2.6M-1.85%-14.14M-29.46%-4.68M49.99%-1.72M-10.34%-3.86M-16.30%-3.89M-121.88%-13.89M-69.77%-3.62M
Minority interest income
Net income attributable to the parent company -25.94%-2.16M68.79%-1.2M33.06%-2.6M-1.85%-14.14M-29.46%-4.68M49.99%-1.72M-10.34%-3.86M-16.30%-3.89M-121.88%-13.89M-69.77%-3.62M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -25.94%-2.16M68.79%-1.2M33.06%-2.6M-1.85%-14.14M-29.46%-4.68M49.99%-1.72M-10.34%-3.86M-16.30%-3.89M-121.88%-13.89M-69.77%-3.62M
Basic earnings per share 0.00%-0.0768.75%-0.0543.75%-0.093.39%-0.57-20.00%-0.1853.33%-0.07-6.67%-0.16-14.29%-0.16-110.71%-0.59-66.67%-0.15
Diluted earnings per share 0.00%-0.0768.75%-0.0543.75%-0.093.39%-0.57-20.00%-0.1853.33%-0.07-6.67%-0.16-14.29%-0.16-110.71%-0.59-66.67%-0.15
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +21.52%
Sample Name
Sample Code
 +18.03%
Sample Name
Sample Code
 +17.02%
4
United States Oil Fund LP
USO
+15.87%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+11.63%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.98%
Sample Name
Sample Code
 +10.85%
Sample Name
Sample Code
 +10.04%
4
Kingsoft Cloud
KC
+7.76%
5
Hesai
HSAI
+7.08%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -